Unknown

Dataset Information

0

Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis.


ABSTRACT: Minimal hepatic encephalopathy (MHE) impairs daily functioning in cirrhosis, but its functional brain impact is not completely understood. To evaluate the effect of rifaximin, a gut-specific antibiotic, on the gut-liver-brain axis in MHE.Rifaximin will reduce endotoxemia, enhance cognition, increase activation during working memory(N-back) and reduce activation needed for inhibitory control tasks.Cirrhotics with MHE underwent baseline endotoxin and cognitive testing, then underwent fMRI, diffusion tensor imaging and MR spectroscopy(MRS). On fMRI, two tasks; N-back (outcome: correct responses) and inhibitory control tests(outcomes: lure inhibition) were performed. All procedures were repeated after 8 weeks of rifaximin. RESULTS were compared before/after rifaximin.20 MHE patients (59.7 years) were included; sixteen completed pre/post-rifaximin scanning with 92% medication compliance. Pre-rifaximin patients had cognitive impairment. At trial-end, there was a significantly higher correct 2-back responses, ICT lure inhibitions and reduced endotoxemia(p?=?0.002). This was accompanied by significantly higher activation from baseline in subcortical structures (thalamus, caudate, insula and hippocampus) and left parietal operculum (LPO) during N-back, decrease in fronto-parietal activation required for inhibiting lures, including LPO during ICT compared to baseline values. Connectivity studies in N-back showed significant shifts in linkages after therapy in fronto-parietal regions with a reduction in fractional anisotropy (FA) but not mean diffusivity (MD), and no change in MRS metabolites at the end of the trial. A significant improvement in cognition including working memory and inhibitory control, and fractional anisotropy without effect on MD or MRS, through modulation of fronto-parietal and subcortical activation and connectivity was seen after open-label rifaximin therapy in MHE.

SUBMITTER: Ahluwalia V 

PROVIDER: S-EPMC4155029 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis.

Ahluwalia Vishwadeep V   Wade James B JB   Heuman Douglas M DM   Hammeke Thomas A TA   Sanyal Arun J AJ   Sterling Richard K RK   Stravitz R Todd RT   Luketic Velimir V   Siddiqui Mohammad S MS   Puri Puneet P   Fuchs Michael M   Lennon Micheal J MJ   Kraft Kenneth A KA   Gilles HoChong H   White Melanie B MB   Noble Nicole A NA   Bajaj Jasmohan S JS  

Metabolic brain disease 20140304 4


<h4>Unlabelled</h4>Minimal hepatic encephalopathy (MHE) impairs daily functioning in cirrhosis, but its functional brain impact is not completely understood. To evaluate the effect of rifaximin, a gut-specific antibiotic, on the gut-liver-brain axis in MHE.<h4>Hypothesis</h4>Rifaximin will reduce endotoxemia, enhance cognition, increase activation during working memory(N-back) and reduce activation needed for inhibitory control tasks.<h4>Methods</h4>Cirrhotics with MHE underwent baseline endotox  ...[more]

Similar Datasets

| S-EPMC8518409 | biostudies-literature
| S-EPMC5621837 | biostudies-literature
| S-EPMC6166307 | biostudies-literature
| S-EPMC5145145 | biostudies-literature
| S-EPMC4880966 | biostudies-literature
| S-EPMC10787503 | biostudies-literature
| S-EPMC4476954 | biostudies-literature
| S-EPMC6870317 | biostudies-literature
| S-EPMC6051941 | biostudies-literature
| S-EPMC5138827 | biostudies-other